Tillotts Pharma AG
Tillotts Pharma AG, headquartered in Switzerland (CH), is a prominent player in the pharmaceutical industry, specialising in gastrointestinal therapies. Founded in 2000, the company has established itself as a leader in developing innovative treatments for conditions such as inflammatory bowel disease and irritable bowel syndrome. With a strong presence in Europe and expanding operations in other regions, Tillotts Pharma is renowned for its unique product offerings, including the well-regarded 5-ASA compound, which sets it apart in the market. The company’s commitment to research and development has led to significant milestones, enhancing its reputation for quality and efficacy. Recognised for its contributions to patient care, Tillotts Pharma AG continues to solidify its market position through strategic partnerships and a focus on unmet medical needs, making it a trusted name in gastrointestinal health.
DitchCarbon Score
How does Tillotts Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tillotts Pharma AG's score of 16 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tillotts Pharma AG's reported carbon emissions
Tillotts Pharma AG, headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data or specific reduction targets. As a company operating in the pharmaceutical industry, Tillotts Pharma is likely aware of the growing importance of sustainability and climate commitments. While no specific emissions figures or reduction initiatives have been disclosed, the industry is increasingly focusing on reducing carbon footprints and enhancing environmental responsibility. It is essential for companies like Tillotts Pharma to establish clear climate commitments and targets to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tillotts Pharma AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
